United States · FDA National Drug Code directory
Regadenoson
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68083-175_549593f6-8cfc-4182-8f3c-a60870187d8f
- Product NDC
- 68083-175
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Regadenoson
- Labeler
- Gland Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220712
- Source listing expiry
- 20261231
Source-listed ingredients
- REGADENOSON — .08 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (68083-175-10) / 5 mL in 1 VIAL (68083-175-01) · 68083-175-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →